Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Document › Details

Evotec AG. (8/10/17). "Press Release: Evotec Announces First Half Year 2017 Results and Corporate Update". Hamburg.

Organisations Organisation Evotec AG (FSE: EVT, TecDAX)
  Group Evotec (Group)
  Organisation 2 Novo Holdings A/S
  Group Novo Group (Group)
Products Product drug discovery services
  Product 2 immunotherapy
Index terms Index term Aptuit–Evotec: investment, 201707–201708 acquisition $300m in cash of Aptuit from Welsh, Carson, Anderson & Stowe
  Index term 2 Evotec–Novo Group: investment, 201702 strategic investment of €90.3m 13.15m new Evotec shares at €6.87/share resulting in 8.9% ownership by Novo A/S
Persons Person Hansen, Gabriele (Evotec 201404 VP Corporate Communications + Investor Relations)
  Person 2 Shalmi, Michael (Novo Group 201702 Managing Director of Large Investment at Novo A/S)

Record changed: 2017-08-18


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

More documents for Evotec (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px

» top